RELAPSE LEUKEMIA
Clinical trials for RELAPSE LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new RELAPSE LEUKEMIA trials appear
Sign up with your email to follow new studies for RELAPSE LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New cell addback aims to slash infection risk in child stem cell recipients
Disease control Recruiting nowThis study tests whether adding a specific type of immune cell (memory T cells) after a stem cell transplant can help prevent serious viral and fungal infections. About 100 children and young adults with blood cancers, immune disorders, or bone marrow failure will receive this ex…
Matched conditions: RELAPSE LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated May 26, 2026 07:30 UTC
-
New drug duo targets tough leukemias in early trial
Disease control Recruiting nowThis study tests whether combining two drugs, revumenib and mezigdomide, is safe for people whose acute leukemia has returned or not responded to prior treatment. It includes adults and teens aged 12+ with specific genetic subtypes (KMT2A-r, NUP98-r, or NPM1-m). The first part fi…
Matched conditions: RELAPSE LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
Indian Kids' genes may predict leukemia drug side effects
Knowledge-focused Recruiting nowThis study follows 500 Indian children with acute lymphoblastic leukemia (ALL) to see how their genes influence side effects from chemotherapy and how well they respond to steroids. Researchers will collect blood samples and track health outcomes over five years. The goal is to f…
Matched conditions: RELAPSE LEUKEMIA
Sponsor: University of Geneva, Switzerland • Aim: Knowledge-focused
Last updated May 26, 2026 07:32 UTC